News

This expanded agreement will continue to offer MedAssets’s customers ICU’s products which provide better patient outcomes and cost reduction as well as cost avoidance, said ICU Medical. Under

Glenmark’s Trandolapril is an angiotensin converting enzyme inhibitor used to treat high blood pressure and is the generic equivalent of Mavik tablets marketed by Abbott Laboratories. This recent

As a result of the completion of this project, PreMD expects to enter into additional agreements with the company for further product development and other skin-testing initiatives. Brent

Strategic Growth International (SGI) will assist the company in establishing a stronger understanding of the investment opportunity AMDL represents while increasing the company’s awareness across global investment communities.

National Cancer Institute’s Bioinformatics Grid (caBIG) initiative is a network of infrastructure and tools that enables the collection, analysis and sharing of data and knowledge along the entire

Dr Schwartz brings to ArQule significant experience in oncology drug development in both the biotechnology and pharmaceutical industries. He was most recently senior vice president of clinical and

The company’s co-development partner, Johnson & Johnson Pharmaceutical R&D, also has filed a corresponding application with the European Medicines Evaluation Agency. The current approval was based on an

Boston Scientific said the transaction will raise pre-tax proceeds in excess of $100 million, the majority of which will be in cash, with a portion in a note

ArthroCare’s DoublePlay is manufactured from a proprietary composite material, the first composite to be used in sports medicine with clinically proven osteoconductivity and replacement by bone. This unique